🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,838 results for “SP” Clear

  1. Zhenyuan capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stable Coronary Heart Disease

    approved small molecule active

    1 trial

  2. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZ 300 mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  3. Zushima plaster with high dose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoarthritis

    approved small molecule completed

    1 trial

  4. a control group

    The First People's Hospital of Lianyungang

    Disorder of Stomach Function and Feeding Problems in Newborn

    approved small molecule completed

    1 trial

  5. albumin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  6. aspirin 100mg/d therapy

    The First People's Hospital of Lianyungang

    Coronary Atherosclerosis

    approved small molecule active

    1 trial

  7. aspirin and clopidogrel

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  8. aspirin and/or clopidogrel

    Takeda

    Early Gastric Cancer

    approved small molecule active

    1 trial

  9. berberine hydrochloride

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  10. biologics treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis

    approved mab active

    1 trial

  11. biphasic insulin aspart 30

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  12. budesonide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Respiratory Distress Syndrome

    approved small molecule active

    1 trial

  13. budesonide/formoterol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cough Variant Asthma

    approved small molecule active

    1 trial

  14. butylphthalide(NBP)

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    approved small molecule completed

    1 trial

  15. conbercept

    Hospital Authority, Hong Kong

    Polypoidal Choroidal Vasculopathy

    approved small molecule completed

    1 trial

  16. conventional dose epinephrine

    Hospital Authority, Hong Kong

    Croup

    approved small molecule active

    1 trial

  17. crizotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Anaplastic Large-Cell Lymphoma

    approved small molecule terminated

    1 trial

  18. cyclosporine or tacrolimus

    Wyeth is now a wholly owned subsidiary of Pfizer

    Graft Rejection

    approved small molecule completed

    1 trial

  19. dapagliflozin

    The First People's Hospital of Lianyungang

    Diabetic Kidney Disease

    approved small molecule active

    1 trial

  20. dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  21. dexmedetomidine

    The First People's Hospital of Lianyungang

    Aged

    approved small molecule completed

    3 trials

  22. dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sleep Quality of Patients Undergoing TURP

    approved small molecule completed

    1 trial

  23. dexmedetomidine hydrochloride for injection

    The First People's Hospital of Lianyungang

    Delirium

    approved small molecule completed

    1 trial

  24. early enteral nutrition

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Pancreatitis

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources